HIV-1 vaccines and co-infection

Bibliography

• COHEN J: AIDS vaccine trial produces disappointment and confusion. Science (2003) 299(5611):1290–1291.
   PubMed Web of Science ®Google Scholar
• RISSOAN M, SOUMELIS, V, N et al.: Reciprocal control of T helper cell differentiation and dendritic cell differentiation. Science (1999) 283:1183–1186.
   PubMed Web of Science ®Google Scholar
• LAVENDER P, COUSINS D, LEE T: Regulation of Th2 cytokine gene transcription. Chem. Immunol (2000) 78:16–29.
   PubMed Web of Science ®Google Scholar
• ZHU J, GUO L, WATSON CJ, HU-LI J, PAUL WE: Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. f Immunol (2001) 166(12):7276–7281.
   PubMed Web of Science ®Google Scholar
• COUSINS DJ, LEE TH, STAYNOV DZ: Cytokine coexpression during human Thl/ Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. .1. Immunol (2002) 169(5):2498–2506.
   Google Scholar
• RAO A, AVNI O: Molecular aspects of T-cell differentiation. Br. Med. Bull. (2000) 56(4):969–984.
   PubMed Web of Science ®Google Scholar
• HOGERVORST E, JURRIAANS S, DE WOLF F et al.: Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.. Dis. (1995) 171(4):811–821.
   Google Scholar
• ZHANG YJ, FRACASSO C, FIORE JR et al.: Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors. Infect. Dis. (1997) 176(5):1180–1187.
   Web of Science ®Google Scholar
• FERRANTELLI F, KITABWALLA M, RASMUSSEN RA et al: Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies-implications for acquired immunodeficiency syndrome vaccine. Infect. Dis. (2004) 189(1):71–74.
   Web of Science ®Google Scholar
• UGEN KE: Vertical transmission of HIV-1 infection. Diagnosis and prevention. f Pla Med. Assoc. (1995) 82(12):825–826.
   Google Scholar
• SAFRIT JT, RUPRECHT R, FERRANTELLI F et al.: Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.1. Acquic Immune Defic. Synth: (2004) 35(2):169–177.
   Google Scholar
• GORNY MK, REVESZ K, WILLIAMS C et al: The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope. Virol (2004) 78(5):2394–2404.
   Web of Science ®Google Scholar
• SCHULKE N, VESANEN MS, SANDERS RW et al.: Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein. f Vim/. (2002) 76(15):7760–7776.
   Google Scholar
• SRIVASTAVA IK, STAMATATOS L, LEGG H et al: Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus. f Vim/. (2002) 76(6):2835–2847.
   Google Scholar
• BARNETT S, LU S, SRIVASTAVA I et al: The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. Vim/. (2001) 75(1):5526–5540.
   Google Scholar
• SRIVASTAVA IK, STAMATATOS L, KAN E et al.: Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate. .1 Virol (2003) 77(20):11244–11259.
   Google Scholar
• BUCKNER C, GINES LG, CJ et al.: Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposes to a R5-tropic SHIV. Virology (2004) 320(1):167–180.
   PubMed Web of Science ®Google Scholar
• ZWICK MB, PARREN PW, SAPHIRE EO et al.: Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human virus type 1 gp120. Virol (2003) 77(10):5863–5876.
   Web of Science ®Google Scholar
• ZWICK MB, KELLEHER R, JENSEN R et al.: A novel human antibody against human immunodeficiency virus type 1 gpl 20 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.j Virol (2003) 77(12):6965–6978.
   Google Scholar
• PINTO LA, SULLIVAN J, JA et al.: Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. f Gin. Invest. (1995) 96:867–876.
   PubMed Web of Science ®Google Scholar
• ROWLAND-JONES S, SUTTON J, ARIYOSHI K et al.: HIV-specific T-cells in HIV exposed but uninfected Gambian women. Nat. Med. (1995) 1:59–64.
   PubMed Web of Science ®Google Scholar
• ROWLAND-JONES SL, NIXON DF, ALDHOUS MC et al.: HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet (1993) 341:860–861.
   PubMed Web of Science ®Google Scholar
• BORROW P, LEWICKI H, HAHN BH, SHAW GM, OLDSTONE MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type-1. f Virol (1994) 68:6103–6110.
   PubMed Web of Science ®Google Scholar
• HULSKOTTE EG, GERETTI AM, SIEBELINK KH et al.: Vaccine-induced virus neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with Simian immunodeficiency virus SIVmac32H(J5). (1996) 69:6289-6296.
   Google Scholar
• SCHMITZ JE, KURODA MJ, SANTRA S et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (1999) 283(5403):857–860.
   PubMed Web of Science ®Google Scholar
• ANDERSSON J, KINLOCH S, SONNERBORG A et al.: Low levels of perform expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection. Infect. Dis. (2002) 185(9):1355–1358.
   Web of Science ®Google Scholar
• HEINTEL T, SESTER M, MM et al.: The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection. AIDS (2002) 16(11):1497–1501.
   PubMed Web of Science ®Google Scholar
• MIGUELES SA, LABORICO AC, SHUPERT WL et al.: HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol (2002) 3(11):1061–1068.
   PubMed Web of Science ®Google Scholar
• LINDOW M, NANSEN A, C et al.: The virus-encoded chemokine vMIP-II inhibits virus-induced Tcl-driven inflammation. .1 Viral. (2003) 77(13):7393–7400.
   Google Scholar
• COCCHI F, DEVICO AL, GARZINO-DEMO A, ARYA SK, GALLO RC, LUSSO P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 270(5243):1811–1815.
   PubMed Web of Science ®Google Scholar
• RUBBERT A, WEISSMAN D, COMBADIERE C et al.: Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects. AIDS Res. Hum. Retroviruses (1997) 13(1):63–69.
   PubMed Web of Science ®Google Scholar
• COPELAND KF, LEITH JG, MCKAY PJ, ROSENTHAL KL: CD8+ T cell supernatants of HIV type 1-infected individuals have opposite effects on long terminal repeat-mediated transcription in T cells and monocytes. AIDS Res. Hum. Retroviruses (1997) 13(1):71–77.
   PubMed Web of Science ®Google Scholar
• SCARLATTI G, TRESOLDI E, BJORNDAL A et al.: In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.. Med. (1997) 3(11):1259–1265.
   Google Scholar
• GAO M, TSUCHIE H, JIN TQ et al.: Difference in susceptibility to CC-chemokines among HIV-1 isolates. Int. .1 STD AIDS (1998) 9(8):471–475.
   Google Scholar
• GARZINO-DEMO A, DEVICO AL, GALLO RC: Chemokine receptors and chemokines in HIV infection. I Clin. Immunol (1998) 18(4):243–255.
   Web of Science ®Google Scholar
• HAROUSE JM, BUCKNER C, GETTIE A et al.: CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques. Proc. Natl. Acad. Sci. USA (2003) 100(19):10977–10982.
   PubMed Web of Science ®Google Scholar
• FRIEDL G, HOFER M, AUBER B et al: Borna disease virus multiplication in mouse organotypic slice cultures is site-specifically inhibited by gamma interferon but not by interleukin- 12.1 Virol. (2004) 78(3):1212–1218.
   Google Scholar
• VICENZI E, BIS WAS P, MENGOZZI M, POLI G: Role of pro-inflammatory cytokines and beta-chemokines in controlling HIV replication.j Leukoc. Biol. (1997) 62:34–40.
   PubMed Web of Science ®Google Scholar
• ROSENBERG ES, BILLINGSLEY JM, CALIENDO AM et al.: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science (1997) 278(5342):1447–1450.
   PubMed Web of Science ®Google Scholar
• YOUNES SA, YASSINE-DIAB B, DUMONT AR et al.: HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. .1 Exp. Med. (2003) 198(12):1909–1922.
   Google Scholar
• NEVA FA, OTTESEN EA: Tropical (filarial) eosinophilia. N Engl I Med. (1978) 298:1129–1131.
   PubMed Web of Science ®Google Scholar
• KLION AD, NUTMAN TB: The role of eosinophils in host defense against helminth parasites. .1 Allergy Clin. Immunol (2004) 113(1):30–37.
   Google Scholar
• REIS MM, HIGUCHI MDE L, BENVENUTI LA et al.: An M situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosome cruzi antigens. Clin. Immunol Immunopethol (1997) 83(2):165–172.
   PubMed Web of Science ®Google Scholar
• ABEL LC, RIZZO LV, IANNI B et al: Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosome cruzi infection.. (2001) 17(1):99–107.
   Google Scholar
• HERNANDEZ-BECERRIL N, NAVA A, REYES PA, MONTEON VM: IgG subclass reactivity to Trypanosome cruzi in chronic chagasic patients. Arch. Cardiol. (2001) 71(3):199–205.
   PubMedGoogle Scholar
• BOTTREL RL, DUTRA WO, MARTINS FA et al: Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leislunania antigen in human cutaneous Leishmaniasis. Infect. Immun. (2001) 69(5):3232–3239.
   PubMed Web of Science ®Google Scholar
• BRYCESON ADM: Leishmaniasis. In: Manson's Tropical Diseases. Cook G (Ed), Saunders, London, UK (1996).
   Google Scholar
• DESSEIN AJ, CHEVILLARD C, MARQUET S, HENRI S, HILLAIRE D, DESSEIN H: Genetics of parasitic infections. Drug Metab. Dispos. (2001) 29(4):484–488.
   PubMed Web of Science ®Google Scholar
• JOSEPH S, JONES FM, KIMANI G etal.: Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for mansoni in Uganda: the differential effect of parasite worm and egg antigens. Infect. Immun. (2004) 72 (2):728–734.
   Google Scholar
• ACOSTA LP, WAINE G, ALIGUI GD, TIU WU, OLVEDA RM, DP: Immune correlate study on human Schistosomajaponicum in a well-defined population in Leyte, Philippines: II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop. (2002) 84(2):137–149.
   Google Scholar
• BUTTERWORTH AE, STURROCK RE HOUBA V, MAHMOUD AA, SHER A, REES PH: Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature (1975) 256(5520):727–729.
   PubMed Web of Science ®Google Scholar
• BUTTERWORTH AE, DAVID JR, FRANKS D et al.: Antibody-dependent eosinophil-mediated damage to 51 Cr-labeled schistosomula of Schistosoma mansont damage by purieid eosinophils. I Exp. Med. (1977) 145(1):136–150.
   PubMed Web of Science ®Google Scholar
• BUTTERWORTH AE, VADAS MA, WASSOM DL et al.: Interactions between human eosinophils and schistosomula of Schistosoma mansoni II. The mechanism of irreversible eosinophil adherence. .1 Exp. Med. (1979) 150(6):1456–1471.
   Google Scholar
• HAGAN P, MOORE PJ, AB, BM, WILKINS HA: In-vitro antibody-dependent killing of schistosomula of Schistosoma haematobium by human eosinophils. Parasite Immunol (1985) 7(6):617–624.
   PubMed Web of Science ®Google Scholar
• KING CL, MEDHAT A, MALHOTRA I etal.: Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. .1. Immunol (1996) 156(12):4715–4721.
   Google Scholar
• BORKOW G, LENG Q, WEISMAN Z etal.: Chronic immune activation associated with intestinal helminth results in impaired signal and anergy. Clin. Invest. (2000) 106(8):1053–1060.
   Google Scholar
• ALLEN JE, MAIZELS RIVI: Immunologyof human helminth infection. Int. Arch. Allergy Inonunol. (1996) 109:3–10.
   PubMed Web of Science ®Google Scholar
• SABIN EA, ARAUJO MI, EM, PEARCE EJ: Impairment of tetanus toxoid-specific Th like immune responses in humans infected with Schistesoma manseni I Infect. Dis. (1996) 173:269–272.
   Google Scholar
• ROWE J, MACAUBAS C, MONGER TM et al.: Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect. Inman. (2000) 68:3873–3877.
   PubMed Web of Science ®Google Scholar
• ACTOR JK, SHIRAI M, MC, BULLER RIVI, SHER A, BERZOFSKY JA: Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Thl cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. USA (1993) 90:948–952.
   PubMed Web of Science ®Google Scholar
• BOT A, HOLZ A, CHRISTEN U et al: Local IL-4 expression in the lung reduces pulmonary influenza-virus specific secondary cytotoxic T cell responses. Virology (2000) 269:66–77.
   PubMed Web of Science ®Google Scholar
• SACKS D, NOBEN-TRAUTH N: The immunology of susceptibility and resistance to Leishrnania major in mice. Nat. Rev Inununol. (2002) 2(11):845–858.
   PubMed Web of Science ®Google Scholar
• BOYER JD: Experimental Leishmania Inept-infection suppresses HIV-1 DNA vaccine induced cellular immune responses. Cells Tissues Organs (2004) (In Press).
   Google Scholar
• CLARKE SR: The critical role of CD40/ CD4OL in the CD4-dependent generation of CD8+ T cell immunity. .1. Leukec. Biel (2000) 67(5):607–614.
   Google Scholar
• SHEDLOCK DJ, WHITMIRE JK, TAN J, MACDONALD AS, AHMED R, SHEN H: Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. .1. Immunel (2003) 170(4):2053–2063.
   Google Scholar
• CARVALHO LH, SANO G, HAFALLA JC, MORROT A, CUROTTO DE LAFAILLE MA, ZAVALA F: IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat. Med. (2002) 8(2):166–170.
   PubMed Web of Science ®Google Scholar
• BULLENS DM, KASRAN A, THIELEMANS K, BAKKUS M, CEUPPENS JL: CD4OL-induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13. Scand. Inununol. (2001) 53(5):455–463.
   PubMed Web of Science ®Google Scholar
• KIM JJ, AYYAVO0 V, BAGARAZZI ML et al.: In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.j. Inununol. (1997) 158(2):816–826.
   Google Scholar
• KIM JJ, BAGARAZZI ML, TRIVEDI N et al.: Engineering of in vivo immune responses to DNA immunization via of costimulatory molecule genes.. Biotechnol (1997) 15(7):641–646.
   Google Scholar
• KIM JJ, NOTTINGHAM LK, SIN JI et al.: CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. I Clin. Invest. (1998) 102(6):1112–1124.
   PubMed Web of Science ®Google Scholar
• KIM JJ, TRIVEDI NN, LK et al: Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Ear. I Innnunal (1998) 28(3):1089–1103.
   PubMed Web of Science ®Google Scholar
• KIM JJ, YANG JS, NOTTINGHAM LK et al.: Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization. Virology (2001) 285(2):204–217.
   PubMed Web of Science ®Google Scholar
• http://www.who.org WHO website.
   Google Scholar
• http://www.cdc.gov for Disease Control and Prevention website.
   Google Scholar